The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis

Author： Ohsugi Yoshiyuki Kishimoto Tadamitsu

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.8, Iss.5, 2008-05, pp. : 669-681

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

By Bayliss Trevor J Smith Jeff T Schuster Michael Dragnev Konstantin H Rigas James R

Expert Opinion on Biological Therapy, Vol. 11, Iss. 12, 2011-12 ,pp. : 1663-1668

Informa Healthcare

Access to resources Recommend Favorite

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis

By Fleischmann Roy Stern Richard Iqbal Imran

Expert Opinion on Biological Therapy, Vol. 4, Iss. 8, 2004-08 ,pp. : 1333-1344

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibody treatments for rheumatoid arthritis

By Bossaller Lukas

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1257-1272

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab in the treatment of rheumatoid arthritis

By Voulgari Paraskevi V Kaltsonoudis Evripidis Papagoras Charalampos Drosos Alexandros A

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1679-1686

Informa Healthcare

Access to resources Recommend Favorite

Etanercept in the treatment of rheumatoid arthritis

By Hunt Laura Emery Paul

Expert Opinion on Biological Therapy, Vol. 13, Iss. 10, 2013-10 ,pp. : 1441-1450

Informa Healthcare

Access to resources Recommend Favorite